Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE SCIENCES vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUVEN LIFE SCIENCES   MYLAN
EQUITY SHARE DATA
    SUVEN LIFE SCIENCES
Mar-23
MYLAN
Dec-18
SUVEN LIFE SCIENCES/
MYLAN
5-Yr Chart
Click to enlarge
High Rs943,967-   
Low Rs452,184-   
Sales per share (Unadj.) Rs0.61,825.4-  
Earnings per share (Unadj.) Rs-5.449.6-  
Cash flow per share (Unadj.) Rs-5.1391.3-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs17.21,974.7-  
Shares outstanding (eoy) m218.07514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x111.81.7 6,633.6%   
Avg P/E ratio x-12.862.0 -20.6%  
P/CF ratio (eoy) x-13.57.9 -172.3%  
Price / Book Value ratio x4.01.6 258.9%  
Dividend payout %00-   
Avg Mkt Cap Rs m15,1311,582,214 1.0%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m1860-   
Avg. sales/employee Rs Th026,833.1-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0728.6-  
INCOME DATA
Net Sales Rs m135939,158 0.0%  
Other income Rs m840-   
Total revenues Rs m220939,158 0.0%   
Gross profit Rs m-1,196243,019 -0.5%  
Depreciation Rs m65175,847 0.0%   
Interest Rs m545,170 0.0%   
Profit before tax Rs m-1,18322,002 -5.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m0-3,500 -0.0%   
Profit after tax Rs m-1,18325,502 -4.6%  
Gross profit margin %-883.625.9 -3,414.9%  
Effective tax rate %0-15.9 0.0%   
Net profit margin %-873.52.7 -32,169.5%  
BALANCE SHEET DATA
Current assets Rs m3,455524,425 0.7%   
Current liabilities Rs m1,050382,364 0.3%   
Net working cap to sales %1,776.015.1 11,741.2%  
Current ratio x3.31.4 239.8%  
Inventory Days Days3,94884 4,724.6%  
Debtors Days Days21893 233.3%  
Net fixed assets Rs m1,373182,181 0.8%   
Share capital Rs m218500 43.6%   
"Free" reserves Rs m3,5350-   
Net worth Rs m3,7531,015,998 0.4%   
Long term debt Rs m01,096,588 0.0%   
Total assets Rs m4,8282,725,301 0.2%  
Interest coverage x-218.81.5 -14,715.3%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x00.3 8.1%   
Return on assets %-24.42.6 -940.3%  
Return on equity %-31.52.5 -1,255.4%  
Return on capital %-31.43.2 -986.5%  
Exports to sales %40.40-   
Imports to sales %839.80-   
Net fx Rs m-1,0820-   
CASH FLOW
From Operations Rs m-1,031195,157 -0.5%  
From Investments Rs m-2,606-100,875 2.6%  
From Financial Activity Rs m3,955-90,916 -4.4%  
Net Cashflow Rs m3171,617 19.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare SUVEN LIFE SCIENCES With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare SUVEN LIFE SCIENCES With: VISTA PHARMA  SAKAR HEALTHCARE   MEDPLUS HEALTH SERVICES  S.S.ORGANICS  ASTRAZENECA PHARMA  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.